These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 31529157
41. Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene. Nakano K, Kubota Y, Mori T, Chiga M, Mori T, Sonoda S, Ueda D, Asakura I, Ikegaya T, Kagawa J, Uchida S, Kubota A. Nephrology (Carlton); 2020 Nov; 25(11):818-821. PubMed ID: 32619053 [Abstract] [Full Text] [Related]
42. A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis. López-Cayuqueo KI, Chavez-Canales M, Pillot A, Houillier P, Jayat M, Baraka-Vidot J, Trepiccione F, Baudrie V, Büsst C, Soukaseum C, Kumai Y, Jeunemaître X, Hadchouel J, Eladari D, Chambrey R. Kidney Int; 2018 Sep; 94(3):514-523. PubMed ID: 30146013 [Abstract] [Full Text] [Related]
43. [Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?]. Ader JL, Waeber B, Suc JM, Brunner HR, Tran-Van T, Durand D, Praddaude F. Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():193-7. PubMed ID: 2973296 [Abstract] [Full Text] [Related]
44. Elevated plasma asymmetric dimethyl-L-arginine in a patient with Gordon syndrome. Wieczorek-Surdacka E, Surdacki A, Bode-Böger SM, Schubert B, Sulowicz W. Nephrol Dial Transplant; 2007 Jan; 22(1):268-71. PubMed ID: 16998213 [No Abstract] [Full Text] [Related]
45. A rare cause of hypertension in childhood: Answers. Kucuk N, Yavas Abalı Z, Abalı S, Canpolat N, Yesil G, Turan S, Bereket A, Guran T. Pediatr Nephrol; 2020 Jan; 35(1):79-82. PubMed ID: 31541304 [No Abstract] [Full Text] [Related]
52. A family with liddle's syndrome caused by a mutation in the beta subunit of the epithelial sodium channel. Kyuma M, Ura N, Torii T, Takeuchi H, Takizawa H, Kitamura K, Tomita K, Sasaki S, Shimamoto K. Clin Exp Hypertens; 2001 Aug; 23(6):471-8. PubMed ID: 11478429 [Abstract] [Full Text] [Related]
57. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism. Sartorato P, Khaldi Y, Lapeyraque AL, Armanini D, Kuhnle U, Salomon R, Caprio M, Viengchareun S, Lombès M, Zennaro MC. Mol Cell Endocrinol; 2004 Mar 31; 217(1-2):119-25. PubMed ID: 15134810 [Abstract] [Full Text] [Related]
58. Pseudohypoaldosteronism: mineralocorticoid unresponsiveness syndrome. Jaruratanasirikul S, Janjindamai W. J Med Assoc Thai; 2000 Aug 31; 83(8):948-52. PubMed ID: 10998851 [Abstract] [Full Text] [Related]
59. Pseudohypoaldosteronism Type II Caused by CUL3 Mutation Presented with Visual Impairment. Wang Q, Cao BY, Su C, Li WJ, Gong CX. Chin Med J (Engl); 2018 Aug 05; 131(15):1879-1881. PubMed ID: 30058590 [No Abstract] [Full Text] [Related]
60. Plasma aldosterone in essential hypertension with low renin activity. Fukuchi S, Nakajima K, Takenouchi T, Nishisato K. Jpn Circ J; 1974 Dec 05; 38(12):1071-7. PubMed ID: 4436936 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]